DXCM Earnings
Dexcom next reports earnings on July 30, 2026. Track record: 4/4 beats.
Next Earnings In
Thursday, July 30, 2026
Current Price
$72.73
EPS Estimate
Earnings Per Share
$0.61
+26.5% YoY
Trailing EPS
Last 12 months earnings
$2.28
Beat Rate
4/4
100%Forward P/E
Price-to-Earnings ratio
23.6
Margin: 19.3%
Analyst Rating
24 analysts
Analyst Sentiment
Strong Buy24 analystsEarnings History
| Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| 2026-03-31 | $0.47 | $0.56 | +19.0% | Beat |
| 2025-12-31 | $0.65 | $0.68 | +4.5% | Beat |
| 2025-09-30 | $0.57 | $0.61 | +7.5% | Beat |
| 2025-06-30 | $0.44 | $0.48 | +8.3% | Beat |
Growth Estimates
| Period | EPS Est. | Revenue Est. | Growth |
|---|---|---|---|
| Current Qtr(0q) | $0.61 | $1.3B | +26.5% |
| Next Qtr(+1q) | $0.67 | $1.3B | +10.2% |
| Current Year(0y) | $2.59 | $5.2B | +23.9% |
| Next Year(+1y) | $3.08 | $5.8B | +18.9% |
Next Quarter Estimates
EPS Estimate
Earnings Per Share
$0.61
Revenue Estimate
$1.3B
Annual EPS Est.
$2.59
+23.9% YoY
DXCM Earnings FAQ
When is DXCM's next earnings date?
Dexcom (DXCM) is expected to report earnings on July 30, 2026. The consensus EPS estimate is $0.61.
Does DXCM usually beat earnings estimates?
Dexcom has beaten Wall Street EPS estimates in 4 of the last 4 quarters (100% beat rate).
What is DXCM's trailing EPS?
Dexcom's trailing twelve-month EPS is $2.28. This is calculated from the last four quarters of reported earnings.
What do analysts think about DXCM?
24 Wall Street analysts cover Dexcom. The consensus rating is "Strong Buy" with an average price target of $85.46, implying 17.5% upside from the current price.